-
1
-
-
0038779569
-
Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes
-
Saniabadi AR, Hanai H, Takeuchi K etal. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003;7:48-59.
-
(2003)
Ther Apher Dial
, vol.7
, pp. 48-59
-
-
Saniabadi, A.R.1
Hanai, H.2
Takeuchi, K.3
-
2
-
-
0037810900
-
Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorption apheresis
-
Hiraishi K, Takeda Y, Shiobara N etal. Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorption apheresis. Ther Apher Dial 2003;7:334-340.
-
(2003)
Ther Apher Dial
, vol.7
, pp. 334-340
-
-
Hiraishi, K.1
Takeda, Y.2
Shiobara, N.3
-
3
-
-
0036696339
-
Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum
-
Kanekura T, Maruyama I, Kanzaki T. Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum. J Am Acad Dermatol 2002;47:320-321.
-
(2002)
J Am Acad Dermatol
, vol.47
, pp. 320-321
-
-
Kanekura, T.1
Maruyama, I.2
Kanzaki, T.3
-
4
-
-
29144453494
-
Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis
-
Kanekura T, Kawahara K, Maruyama I, Kanzaki T. Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis. Ther Apher Dial 2005;9:292-296.
-
(2005)
Ther Apher Dial
, vol.9
, pp. 292-296
-
-
Kanekura, T.1
Kawahara, K.2
Maruyama, I.3
Kanzaki, T.4
-
5
-
-
0037757690
-
Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresis
-
Kanekura T, Yoshii N, Yonezawa T, Kawabata H, Saruwatari H, Kanzaki T. Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2003;49:329-332.
-
(2003)
J Am Acad Dermatol
, vol.49
, pp. 329-332
-
-
Kanekura, T.1
Yoshii, N.2
Yonezawa, T.3
Kawabata, H.4
Saruwatari, H.5
Kanzaki, T.6
-
6
-
-
0842310885
-
Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis
-
Kanekura T, Kawabata H, Maruyama I, Kanzaki T. Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2004;50:242-246.
-
(2004)
J Am Acad Dermatol
, vol.50
, pp. 242-246
-
-
Kanekura, T.1
Kawabata, H.2
Maruyama, I.3
Kanzaki, T.4
-
7
-
-
3242682758
-
Treatment of Behcet's disease with granulocyte and monocyte adsorption apheresis
-
Kanekura T, Gushi A, Iwata M etal. Treatment of Behcet's disease with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2004;51:S83-87.
-
(2004)
J Am Acad Dermatol
, vol.51
-
-
Kanekura, T.1
Gushi, A.2
Iwata, M.3
-
8
-
-
3242749764
-
Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresis
-
Kanekura T, Terasaki K, Higashi Y etal. Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresis. Clin Exp Dermatol 2004;29:410-412.
-
(2004)
Clin Exp Dermatol
, vol.29
, pp. 410-412
-
-
Kanekura, T.1
Terasaki, K.2
Higashi, Y.3
-
9
-
-
19544389660
-
Granulocyte and monocyte adsorption apheresis for leg ulcers in a patient with rheumatoid arthritis
-
Kanekura T, Mochitomi Y, Fujimoto S, Kawahara K, Maruyama I, Kanzaki T. Granulocyte and monocyte adsorption apheresis for leg ulcers in a patient with rheumatoid arthritis. J Am Acad Dermatol 2005;52:1108-1109.
-
(2005)
J Am Acad Dermatol
, vol.52
, pp. 1108-1109
-
-
Kanekura, T.1
Mochitomi, Y.2
Fujimoto, S.3
Kawahara, K.4
Maruyama, I.5
Kanzaki, T.6
-
10
-
-
33745550486
-
Granulocyte and monocyte adsorption apheresis for cutaneous allergic vasculitis
-
Kanekura T, Yoshii N, Kawahara K etal. Granulocyte and monocyte adsorption apheresis for cutaneous allergic vasculitis. Ther Apher Dial 2006;10:287-290.
-
(2006)
Ther Apher Dial
, vol.10
, pp. 287-290
-
-
Kanekura, T.1
Yoshii, N.2
Kawahara, K.3
-
11
-
-
84858449311
-
Granulocyte and monocyte adsorption apheresis as an effective treatment for Reiter disease
-
Yoshifuku A, Oyama K, Ibusuki A etal. Granulocyte and monocyte adsorption apheresis as an effective treatment for Reiter disease. Clin Exp Dermatol 2012;37:241-244.
-
(2012)
Clin Exp Dermatol
, vol.37
, pp. 241-244
-
-
Yoshifuku, A.1
Oyama, K.2
Ibusuki, A.3
-
12
-
-
0942300673
-
Improvement of SLE skin rash with granulocyte and monocyte adsorption apheresis
-
Kanekura T, Hashiguchi T, Mera Y etal. Improvement of SLE skin rash with granulocyte and monocyte adsorption apheresis. Dermatology 2004;208:79-80.
-
(2004)
Dermatology
, vol.208
, pp. 79-80
-
-
Kanekura, T.1
Hashiguchi, T.2
Mera, Y.3
-
13
-
-
0027398448
-
A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen
-
Diamond MS, Springer TA. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol 1993;120:545-556.
-
(1993)
J Cell Biol
, vol.120
, pp. 545-556
-
-
Diamond, M.S.1
Springer, T.A.2
-
14
-
-
0024208261
-
The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B
-
Corbi AL, Kishimoto TK, Miller LJ, Springer TA. The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J Biol Chem 1988;263:12403-12411.
-
(1988)
J Biol Chem
, vol.263
, pp. 12403-12411
-
-
Corbi, A.L.1
Kishimoto, T.K.2
Miller, L.J.3
Springer, T.A.4
-
15
-
-
0023749291
-
Amino acid sequence of the alpha subunit of human leukocyte adhesion receptor Mo1 (complement receptor type 3)
-
Arnaout MA, Gupta SK, Pierce MW, Tenen DG. Amino acid sequence of the alpha subunit of human leukocyte adhesion receptor Mo1 (complement receptor type 3). J Cell Biol 1988;106:2153-2158.
-
(1988)
J Cell Biol
, vol.106
, pp. 2153-2158
-
-
Arnaout, M.A.1
Gupta, S.K.2
Pierce, M.W.3
Tenen, D.G.4
-
16
-
-
0019953149
-
Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor
-
Beller DI, Springer TA, Schreiber RD. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J Exp Med 1982;156:1000-1009.
-
(1982)
J Exp Med
, vol.156
, pp. 1000-1009
-
-
Beller, D.I.1
Springer, T.A.2
Schreiber, R.D.3
-
17
-
-
0029961891
-
Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion
-
Cai TQ, Wright SD. Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion. J Exp Med 1996;184:1213-1223.
-
(1996)
J Exp Med
, vol.184
, pp. 1213-1223
-
-
Cai, T.Q.1
Wright, S.D.2
-
18
-
-
0026054779
-
Adherence of neutrophils to hemodialysis membranes: role of complement receptors
-
Cheung AK, Hohnholt M, Gilson J. Adherence of neutrophils to hemodialysis membranes: role of complement receptors. Kidney Int 1991;40:1123-1133.
-
(1991)
Kidney Int
, vol.40
, pp. 1123-1133
-
-
Cheung, A.K.1
Hohnholt, M.2
Gilson, J.3
-
19
-
-
33745558583
-
Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: evidence that GCAP removes Mac-1-expressing neutrophils
-
Kanekura T, Hiraishi K, Kawahara K, Maruyama I, Kanzaki T. Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: evidence that GCAP removes Mac-1-expressing neutrophils. Ther Apher Dial 2006;10:247-256.
-
(2006)
Ther Apher Dial
, vol.10
, pp. 247-256
-
-
Kanekura, T.1
Hiraishi, K.2
Kawahara, K.3
Maruyama, I.4
Kanzaki, T.5
-
20
-
-
0037947382
-
Tazarotene cream in the treatment of psoriasis: two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks
-
Tazaroten Cream Clinical Study Group.
-
Weinstein GD, Koo JYM, Krueger GG etal. Tazaroten Cream Clinical Study Group. Tazarotene cream in the treatment of psoriasis: two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. J Am Acad Dermatol 2003;48:760-767.
-
(2003)
J Am Acad Dermatol
, vol.48
, pp. 760-767
-
-
Weinstein, G.D.1
Koo, J.Y.M.2
Krueger, G.G.3
-
21
-
-
0036270464
-
Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis
-
Kashiwagi N, Sugimura K, Koiwai H etal. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002;47:1334-1341.
-
(2002)
Dig Dis Sci
, vol.47
, pp. 1334-1341
-
-
Kashiwagi, N.1
Sugimura, K.2
Koiwai, H.3
-
22
-
-
84875424125
-
Therapeutic depletion of myeloid lineage leucocytes in patients with generalized pustular psoriasis
-
Ikeda S, Takahashi H, Suga Y etal. Therapeutic depletion of myeloid lineage leucocytes in patients with generalized pustular psoriasis. J Am Acad Dermatol 2013;68:609-617.
-
(2013)
J Am Acad Dermatol
, vol.68
, pp. 609-617
-
-
Ikeda, S.1
Takahashi, H.2
Suga, Y.3
|